comparemela.com

Latest Breaking News On - Oncology at jena university hospital - Page 1 : comparemela.com

Novartis' Scemblix receives EC approval for chronic myeloid leukaemia

Novartis' Scemblix receives EC approval for chronic myeloid leukaemia
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United statesAndreas hochhausNovarti scemblixCommittee for medicinal products humanOncology at jena university hospitalEuropean medicines agencyEuropean commissionMedical oncologyJena university hospitalMedicinal products

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia | Small Molecules

Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia

United statesUnited kingdomEast hanoverNovartis scemblixHaseeb ahmadAndreas hochhausOncology at jena university hospitalAmerican society for clinical oncologyEuropean hematology associationEuropean commissionHead of the department hematologyApproval programEuropean unionEuropean medicines agencyNovartis pharmaceuticals corpCommittee for medicinal products human use

Novartis Pharma AG: Novartis receives positive CHMP opinion for Scemblix, a novel treatment for adult patients with chronic myeloid leukemia

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least

United statesEast hanoverIsabella zinckHaseeb ahmadAmy wolfNicole zinsli sommFloriana riccio furnariSamir shahParag mahantiJulie masowSloan simpsonAndreas hochhausAlina levchukOncology at jena university hospitalAmerican society for clinical oncologyEuropean hematology association

vimarsana © 2020. All Rights Reserved.